These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 26243012)

  • 41. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
    Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
    Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
    Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
    Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
    Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
    Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
    Rizzo FM; Palmirotta R; Marzullo A; Resta N; Cives M; Tucci M; Silvestris F
    BMC Cancer; 2016 Feb; 16():87. PubMed ID: 26867653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastrointestinal tract spindle cell tumors with interstitial cells of Cajal: Prevalence excluding gastrointestinal stromal tumors.
    Lee SJ; Hwang CS; Kim A; Kim K; Choi KU
    Oncol Lett; 2016 Aug; 12(2):1287-1292. PubMed ID: 27446428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A smooth muscle-derived, Braf-driven mouse model of gastrointestinal stromal tumor (GIST): evidence for an alternative GIST cell-of-origin.
    Kondo J; Huh WJ; Franklin JL; Heinrich MC; Rubin BP; Coffey RJ
    J Pathol; 2020 Dec; 252(4):441-450. PubMed ID: 32944951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
    Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
    Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
    Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
    Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastrointestinal stromal tumors: differential diagnosis.
    Dow N; Giblen G; Sobin LH; Miettinen M
    Semin Diagn Pathol; 2006 May; 23(2):111-9. PubMed ID: 17193824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential Expression of
    Yuan J; Kihara T; Kimura N; Hashikura Y; Ohkouchi M; Isozaki K; Takahashi T; Nishida T; Ito A; Hirota S
    Pathol Oncol Res; 2021; 27():602008. PubMed ID: 34257559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.
    Théou-Anton N; Tabone S; Brouty-Boyé D; Saffroy R; Ronnstrand L; Lemoine A; Emile JF
    Br J Cancer; 2006 Apr; 94(8):1180-5. PubMed ID: 16570044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
    Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; van Ijcken WF; Wozniak A; Sciot R; Rutkowski P; Schöffski P; Taguchi T; Mathijssen RH; Verweij J; Sleijfer S; Debiec-Rychter M; Wiemer EA
    Br J Cancer; 2013 Sep; 109(6):1625-35. PubMed ID: 23969726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
    Swalchick W; Shamekh R; Bui MM
    Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens.
    Willmore-Payne C; Layfield LJ; Holden JA
    Cancer; 2005 Jun; 105(3):165-70. PubMed ID: 15822120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
    Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
    Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
    Zheng S; Chen LR; Wang HJ; Chen SZ
    Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour.
    Parfitt JR; Rodriguez-Justo M; Feakins R; Novelli MR
    Histopathology; 2008 Jun; 52(7):816-23. PubMed ID: 18494611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting ETV1 in gastrointestinal stromal tumors: tripping the circuit breaker in GIST?
    Duensing A
    Cancer Discov; 2015 Mar; 5(3):231-3. PubMed ID: 25749973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.